Medical
About Us
Investor Relations
To respond to the unfolding changes in its business environment and operate from a perspective of sustainable management, the Eiken Group has defined as EIKEN ROAD MAP 2030, with 2030 as the target year for its fulfillment, and clarified the vision of the Eiken Group in 2030 as “EIKEN Vision 2030”
EIKEN ROAD MAP 2030 identifies the Group’s existing business domains as its core businesses while specifying three areas as key business fields: Contribution to the prevention and treatment of cancer; Contribution to the eradication and control of infectious diseases; and Provision of products and services that play a valuable role in health management.
Index | Targets for FY2030 | |
Growth | Net sales | JPY 75 billion |
Overseas sales as share of total | 40% or greater | |
Profitability | Operating income margin | 20% or greater |
Capital efficiency | Return on equity (ROE) | 15% or greater |
As a Group whose mission is to protect the health of people worldwide, the Eiken Group is addressing issues not only of healthcare but also of the environment, society and governance. For each materiality, the Group sets key performance indicators and monitors its progress toward achieving them. In addition to tracking its performance on the KPIs, the Eiken Group reflects this performance in its evaluation of executive officers’ performance and in their remuneration.
Please see the sustainability website for details
The Group has formulated and announced its second medium-term management plan (fiscal year ending March 2026 to fiscal year ending March 2028) for FY 2030 . Under the slogan of "Challenges to Innovation," we will pursue challenge of thorough reform to reinforce earnings strength. We will tackle key management issues centered on "Business strateges," "Financial Capital strateges," and "Governance," which we have established as our basic policy.
Management
policy
Stock
Information